Krishna Gorti
individual
About
Krishna Gorti, MD FRCS, is a biopharma executive currently serving as Head of Corporate Development at Attralus, an amyloidosis-focused biotech company. Attralus says he previously served at The Medicines Company in investor relations, business development, and strategy, and earlier worked as a biotechnology equity research analyst at J.P. Morgan, Piper Jaffray, and Rodman & Renshaw. His background also includes physician training in otolaryngology and head and neck surgery plus clinical and translational research.
Areas of interest
biotechamyloidosisrare disease therapeuticsmolecular imagingclinical developmentcorporate developmentinvestor relationsbiotechnology equity research